Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of Helicobacter pylori eradication regimens in children
PACTR202201686010590Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of omeprazole + amoxicillin + clarithromycin in Helicobacter pylori infection (5 arms), sponsored by Alexandria University. Primary endpoint: fecal H. pylori antigen. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
omeprazole + amoxicillin + clarithromycin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202201686010590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202201686010590.